Active Ingredient: ACETYLCYSTEINE
Proprietary Name: ACETYLCYSTEINE
Dosage Form; Route of Administration: SOLUTION; INHALATION, ORAL
Strength: 20%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A205643
Product Number: 001
Approval Date: Nov 1, 2023
Applicant Holder Full Name: EXELA PHARMA SCIENCES LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information